In the management of severe traumatic brain injury and refractory intracranial hypertension, various interventions are utilized to lower intracranial pressure (ICP) while maintaining adequate cerebral perfusion. Match each advanced neurocritical care intervention with its precise physiological mechanism of action and primary clinical limitation.
- Induced hypocapnia (target PaCO2 30-35 mmHg)Decreases cerebral blood volume via pH-mediated arteriolar vasoconstriction; efficacy diminishes rapidly due to cerebrospinal fluid bicarbonate equilibration.
- Intravenous hypertonic saline administrationEstablishes an osmotic gradient across an intact blood-brain barrier to reduce parenchymal water; limited by the risk of hyperchloremic non-anion gap metabolic acidosis.
- High-dose barbiturate therapyReduces ICP through profound suppression of the cerebral metabolic rate of oxygen (CMRO2); severely limited by dose-dependent systemic myocardial depression and hypotension.
- Decompressive craniectomySurgically circumvents the Monro-Kellie doctrine by expanding the fixed total intracranial volume; associated with late complications such as syndrome of the trephined.
Cevap
Induced hypocapnia matches with pH-mediated vasoconstriction. Hypertonic saline matches with osmotic gradient and hyperchloremic acidosis. High-dose barbiturate therapy matches with suppression of CMRO2 and myocardial depression. Decompressive craniectomy matches with expanding fixed volume and syndrome of the trephined.
Each neurocritical care intervention targets a specific component of the Monro-Kellie doctrine (brain parenchyma, cerebrospinal fluid, or blood). Hyperventilation rapidly constricts vessels to decrease blood volume. Hyperosmolar therapy shrinks the brain parenchyma. Barbiturates reduce metabolic demand and coupled blood flow. Craniectomy increases the total allowable volume in the intracranial vault.
Adım Adım Çözüm
Anahtar Kavram
Management of Elevated Intracranial Pressure